Abdulaziz Ibrahim holds a master's degree in pharmaceutical sciences. His master’s research, titled “Comparative Effects of DPP-4 Inhibitors, SGLT2 Inhibitors, and Their Combination on Lipid Profiles in Type 2 Diabetes Mellitus: A Retrospective Study in Jordanian Government Hospitals," focused on how antidiabetic therapies affect lipid profiles in patients with type 2 diabetes. His research interests include diabetes pharmacotherapy, clinical pharmacy, pharmacoepidemiology, medication safety, and evidence-based pharmaceutical research.
Abdulaziz Ibrahim holds a master's degree in pharmaceutical sciences. His master’s research, titled “Comparative Effects of DPP-4 Inhibitors, SGLT2 Inhibitors, and Their Combination on Lipid Profiles in Type 2 Diabetes Mellitus: A Retrospective Study in Jordanian Government Hospitals," focused on how antidiabetic therapies affect lipid profiles in patients with type 2 diabetes. His research interests include diabetes pharmacotherapy, clinical pharmacy, pharmacoepidemiology, medication safety, and evidence-based pharmaceutical research.